EA202192257A1 - Комбинация кремния и магния для предупреждения и лечения мышечных судорог - Google Patents

Комбинация кремния и магния для предупреждения и лечения мышечных судорог

Info

Publication number
EA202192257A1
EA202192257A1 EA202192257A EA202192257A EA202192257A1 EA 202192257 A1 EA202192257 A1 EA 202192257A1 EA 202192257 A EA202192257 A EA 202192257A EA 202192257 A EA202192257 A EA 202192257A EA 202192257 A1 EA202192257 A1 EA 202192257A1
Authority
EA
Eurasian Patent Office
Prior art keywords
silicon
contrusions
muscle
prevention
treatment
Prior art date
Application number
EA202192257A
Other languages
English (en)
Inventor
Баудевейн Луис Рене Андре Колсат
Кристианне Аугуста Адольф Ван Ворен
Original Assignee
Био Минералз Нв
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Био Минералз Нв filed Critical Био Минералз Нв
Publication of EA202192257A1 publication Critical patent/EA202192257A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Фармацевтическая композиция, содержащая фармацевтически эффективное количество биодоступного кремния в суточной дозе по меньшей мере 3 мг элементарного кремния и фармацевтически эффективное количество соединения магния в суточной дозе 50-500 мг элементарного магния. Композицию применяют для предупреждения, ингибирования и/или лечения мышечных судорог, таких как судороги скелетных мышц.
EA202192257A 2019-02-15 2020-02-14 Комбинация кремния и магния для предупреждения и лечения мышечных судорог EA202192257A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19157526.5A EP3695843A1 (en) 2019-02-15 2019-02-15 Medicament for the prevention and treatment of muscle cramps
PCT/EP2020/053912 WO2020165415A1 (en) 2019-02-15 2020-02-14 Combination of silicon and magnesium for the prevention and treatment of muscle cramps

Publications (1)

Publication Number Publication Date
EA202192257A1 true EA202192257A1 (ru) 2021-11-01

Family

ID=65443783

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192257A EA202192257A1 (ru) 2019-02-15 2020-02-14 Комбинация кремния и магния для предупреждения и лечения мышечных судорог

Country Status (11)

Country Link
US (1) US20220143078A1 (ru)
EP (2) EP3695843A1 (ru)
JP (1) JP2022520962A (ru)
KR (1) KR20220004956A (ru)
CN (1) CN113853202A (ru)
AU (1) AU2020223517A1 (ru)
BR (1) BR112021015682A2 (ru)
CA (1) CA3129115A1 (ru)
EA (1) EA202192257A1 (ru)
IL (1) IL285491A (ru)
WO (1) WO2020165415A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202200009089A1 (it) 2022-05-04 2023-11-04 Geofarma S R L Composizione a base di silicio biodisponibile e vitamine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922765A (en) * 1996-01-18 1999-07-13 Fleming & Company, Pharmaceuticals Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength
US20050196434A1 (en) * 2004-03-04 2005-09-08 Brierre Barbara T. Pharmaceutical composition and method for the transdermal delivery of magnesium
US20050220865A1 (en) * 2004-04-02 2005-10-06 Koleng John J Compressed composition comprising magnesium salt
EP3307083A4 (en) * 2015-06-11 2019-05-22 Beachbody, LLC COMPOSITIONS AND METHODS FOR IMPROVING TRAINING PERFORMANCE AND RECREATION

Also Published As

Publication number Publication date
EP3923955A1 (en) 2021-12-22
CN113853202A (zh) 2021-12-28
KR20220004956A (ko) 2022-01-12
WO2020165415A1 (en) 2020-08-20
CA3129115A1 (en) 2020-08-20
BR112021015682A2 (pt) 2021-10-26
JP2022520962A (ja) 2022-04-04
IL285491A (en) 2021-09-30
US20220143078A1 (en) 2022-05-12
EP3695843A1 (en) 2020-08-19
AU2020223517A1 (en) 2021-08-19

Similar Documents

Publication Publication Date Title
CR20210563A (es) Compuestos y métodos para el tratamiento de covid-19
MA40111B1 (fr) Dérivés du tétrahydronaphtalène inhibant la protéine mcl-1
RU2015107877A (ru) Способы лечения болезни альцгеймера и фармацевтические композиции
HUP0101268A2 (hu) A női nemi diszfunkció kezelésére alkalmas gyógyszerkészítmények
TW200639159A (en) Treatment of pain
BR9908030A (pt) Composição farmacêutica compreendendo uma ou mais unidades de dose oralmente ministráveis, e, processos para prepará-la, para uso da mesma, e para tratar uma condição ou distúrbio médico em um indivìduo em que tratamento com um inibidor da ciclooxigenase-2 é indicado
TW200806299A (en) Treatment of pain
CL2020000860A1 (es) Compuestos monobactámicos cromanos para el tratamiento de infecciones bacterianas.
RU2017116740A (ru) Комбинации для лечения рассеянного склероза
BR0208563A (pt) composições de n-acetilcisteìna e métodos para o tratamento e prevenção de toxidade de droga
MX2021006156A (es) Compuestos utiles en la terapia para el vih.
NZ745065A (en) Methods for treatment and prophylaxis of hiv and aids
ZA202006072B (en) Ret inhibitor for use in treating cancer having a ret alteration
EA201990249A1 (ru) Применение и режим дозирования терапевтических агентов при эндометриозе
RU2017120184A (ru) Лекарства для замедления течения болезни паркинсона
EA202192257A1 (ru) Комбинация кремния и магния для предупреждения и лечения мышечных судорог
PH12020500666A1 (en) Pladienolide compounds and their use
HUP0301828A2 (hu) Apomorfin alkalmazása nemi mżködészavar meghatározott apomorfin-plazmakoncentrációval történż kezelésre szolgáló készítmények elżállítására
MA39447A1 (fr) (s)-pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine
MX2020007941A (es) Metodo para prevenir o tratar enfermedad de alzheimer.
SE9001308D0 (sv) Foerfarande foer att behandla och foerebygga foertvining av bensubstans
MX2019011558A (es) Nuevos compuestos sustituidos de n'-hidroxicarbamimidoil-1,2,5-oxa diazol como inhibidores de indolamina 2,3-dioxigenasa (ido).
PH12020551620A1 (en) Compositions for preventing or treating dry eye
EA202193050A1 (ru) Фармацевтическая комбинация, включающая тразодон, для лечения нейропатической боли
RU2020101999A (ru) Ликофлигозин для лечения неалкогольного стеатогепатита